Literature DB >> 11342541

Analysis of fertilin alpha (ADAM1)-mediated sperm-egg cell adhesion during fertilization and identification of an adhesion-mediating sequence in the disintegrin-like domain.

G E Wong1, X Zhu, C E Prater, E Oh, J P Evans.   

Abstract

Fertilin alpha (also known as ADAM1) is a member of the ADAM (A disintegrin and A metalloprotease domain) family of proteins. In this study, we examine the mechanism of mouse fertilin alpha's in adhesion of sperm to the egg plasma membrane during fertilization. We find that recombinant forms of fertilin alpha corresponding to either the disintegrin-like domain or the cysteine-rich domain and the EGF-like repeat can perturb sperm-egg binding, suggesting that both of these domains can participate in fertilin alpha-mediated adhesion events. In further examination of the fertilin alpha disintegrin-like domain, we find that a subdomain of disintegrin-like domain with the sequence DLEECDCG outside the putative disintegrin loop but with homology to the fertilin beta disintegrin loop can inhibit the binding of both sperm and recombinant fertilin alpha to eggs, suggesting that this is an adhesion-mediating motif of the fertilin alpha disintegrin-like domain. This sequence also inhibits the binding of recombinant fertilin beta to eggs and thus is the first peptide sequence found to block two different sperm ligands. Finally, a monoclonal antibody to the tetraspanin protein CD9, KMC.8, inhibited the binding of recombinant fertilin alpha to eggs in one type of binding assay, suggesting that, under certain conditions, fertilin alpha may interact with a KMC.8-sensitive binding site on the egg plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342541     DOI: 10.1074/jbc.M101637200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Immunohistochemical distribution of the tetraspanin CD9 in normal porcine tissues.

Authors:  Noemí Yubero; Angeles Jiménez-Marín; Concepción Lucena; Manuel Barbancho; Juan J Garrido
Journal:  Mol Biol Rep       Date:  2010-06-29       Impact factor: 2.316

2.  Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface.

Authors:  Kasper J Mygind; Theresa Störiko; Marie L Freiberg; Jacob Samsøe-Petersen; Jeanette Schwarz; Olav M Andersen; Marie Kveiborg
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

3.  The transmembrane homotrimer of ADAM 1 in model lipid bilayers.

Authors:  Siok Wan Gan; Lin Xin; Jaume Torres
Journal:  Protein Sci       Date:  2006-12-22       Impact factor: 6.725

Review 4.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

5.  Positive selection neighboring functionally essential sites and disease-implicated regions of mammalian reproductive proteins.

Authors:  Claire C Morgan; Noeleen B Loughran; Thomas A Walsh; Alan J Harrison; Mary J O'Connell
Journal:  BMC Evol Biol       Date:  2010-02-11       Impact factor: 3.260

6.  Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling.

Authors:  Jian Xu; Xinfeng Liu; Jieli Chen; Alex Zacharek; Xu Cui; Smita Savant-Bhonsale; Michael Chopp; Zhenguo Liu
Journal:  Cell Transplant       Date:  2009-09-28       Impact factor: 4.064

7.  Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.

Authors:  Simon C Wagstaff; Gavin D Laing; R David G Theakston; Christina Papaspyridis; Robert A Harrison
Journal:  PLoS Med       Date:  2006-06       Impact factor: 11.069

Review 8.  The Role of the Epididymis and the Contribution of Epididymosomes to Mammalian Reproduction.

Authors:  Emma R James; Douglas T Carrell; Kenneth I Aston; Timothy G Jenkins; Marc Yeste; Albert Salas-Huetos
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.